Skip to main content
Log in

Pacemaker implantation after TAVI: predictors of AV block persistence

  • Original Paper
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

Abstract

Aims

Approximately every fifth patient undergoing transcatheter aortic valve implantation (TAVI) requires a permanent pacemaker (PPM) after the procedure. The aim of this study was to analyse predictors of atrioventricular block III° (AVBIII) persistence with concurrent PPM dependency after TAVI.

Methods and results

Between 2010 and 2015 a total of 1198 patients underwent TAVI at the Kerckhoff Heart and Thorax Center, Germany. After exclusion of patients with prior PPM (n = 173) 14.7% (n = 176) of the patients underwent PPM implantation after the procedure. Independent predictors of PPM implantation were pre-existing right bundle branch block (RBBB, p < 0.001) and implantation of a CoreValve prosthesis (p < 0.001). A subgroup of patients with a newly implanted PPM (n = 102) were followed-up for a median of 73 (IQR 62–85) days. The leading indication for PPM implantation was AVBIII in 74.5% (76/102). Of these patients only 22.4% (17/76) had persistent AVBIII at follow-up. Predictors of AVBIII persistence were prior RBBB (p = 0.04), postdilatation (p = 0.006) and higher mean aortic valve gradient prior to implantation (p = 0.013). PPMs were implanted earlier in patients with persisting AVBIII [1 day (IQR0–2.5) vs. 4 days (IQR2–7); p < 0.001]. Early PPM implantation after TAVI was the only independent predictor of persistent AVBIII [OR 1.36 (95% 1.05–1.75); p = 0.02].

Conclusion

The long-term persistence of AVBIII is generally low after TAVI. Therefore, it may be wise to postpone the indication for PPM implantation for a couple of days. The only predictors of a lack of recovery of the AVB are prior RBBB, higher mean aortic valve gradients and postdilatation of the prosthesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Smith C, Leon M, Mack M et al (2011) Transcatheter versus surgical aotic-valve replacement in high-risk patients. N Engl J Med 364:2187–2198

    Article  CAS  PubMed  Google Scholar 

  2. Leon M, Smith C, Mack M et al (2010) Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363:1597–1607

    Article  CAS  PubMed  Google Scholar 

  3. Gaede L, Möllmann H (2015) Transcatheter aortic valve implantation (TAVI): current perspectives. Herz 54:742–751

    Article  Google Scholar 

  4. Gaede L, Kim W-K, Blumenstein J et al (2017) Temporal trends in transcatheter and surgical aortic valve replacement. Herz 42:316–324

    Article  CAS  PubMed  Google Scholar 

  5. Gaede L, Blumenstein J, Kim W-K et al (2017) Trends in aortic valve replacement in Germany in 2015: transcatheter versus isolated surgical aortic valve repair. Clin Res Cardiol 106:411–419

    Article  PubMed  Google Scholar 

  6. Möllmann H, Bestehorn K, Bestehorn M et al (2016) In-hospital outcome of transcatheter vs. surgical aortic valve replacement in patients with aortic valve stenosis—complete dataset of patients treated in 2013 in Germany. Clin Res Cardiol 105:553–559

    Article  PubMed  Google Scholar 

  7. Doenst T, Strüning C, Moschovas A et al (2016) Cardiac surgery 2015 reviewed. Clin Res Cardiol 105:801–814

    Article  PubMed  Google Scholar 

  8. Seidler T, M H, Puls M et al (2016) Feasibility and outcomes of interventional treatment for vascular access site complications following transfemoral aortic valve implantation. Clin Res Cardiol 106:183–191

    Article  PubMed  Google Scholar 

  9. Arsalan M, Filardo G, Kim WK et al (2016) Prognostic value of body mass index and body surface area on clinical outcomes after transcatheter aortic valve implantation. Clin Res Cardiol 105:1042–1048

    Article  PubMed  Google Scholar 

  10. Erkapic D, De Rosa S, Kelava A et al (2012) Risk for permanent pacemaker after transcatheter aortic valve implantation: a comprehensive analysis of the literature. J Cardiovasc Electrophysiol 23:391–397

    Article  PubMed  Google Scholar 

  11. Walther T, Hamm CW, Schuler G et al (2015) Peri-operative results and complications in 15,964 transcatheter aortic valve implantations from the German Aortic valve RegistrY (GARY). J Am Coll Cardiol 65:2173–2180

    Article  PubMed  Google Scholar 

  12. Leon MB, Smith CR, Mack MJ et al (2016) Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med NEJM 374:1609–1620

    Article  CAS  PubMed  Google Scholar 

  13. Reardon MJ, Van Mieghem NM, Popma JJ et al (2017) Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med 376:1321–1331

    Article  PubMed  Google Scholar 

  14. Mohr FW, Holzhey D, Möllmann H et al (2014) The German Aortic Valve Registry: 1-year results from 13,680 patients with aortic valve disease†. Eur J cardio-thoracic Surg 46:808–816

    Article  Google Scholar 

  15. Fraccaro C, Buja G, Tarantini G et al (2011) Incidence, predictors, and outcome of conduction disorders after transcatheter self-expandable aortic valve implantation. Am J Cardiol 107:747–754

    Article  PubMed  Google Scholar 

  16. Nazif TM, Dizon JM, Hahn RT et al (2015) Predictors and clinical outcomes of permanent pacemaker implantation after transcatheter aortic valve replacement. JACC Cardiovasc Interv 8:60–69

    Article  PubMed  Google Scholar 

  17. Urena M, Rodés-Cabau J (2015) Permanent pacemaker implantation following transcatheter aortic valve replacement. JACC Cardiovasc Interv 8:70–73

    Article  PubMed  Google Scholar 

  18. Schymik G, Tzamalis P, Bramlage P et al (2015) Retro Clinical impact of a new left bundle branch block following TAVI implantation: 1-year results of the TAVIK cohort. Clin Res Cardiol 104:351–362

    Article  PubMed  Google Scholar 

  19. Gonska B, Seeger J, Keßler M et al (2017) Predictors for permanent pacemaker implantation in patients undergoing transfemoral aortic valve implantation with the Edwards Sapien 3 valve. Clin Res Cardiol. doi:10.1007/s00392-017-1093-2 (epub ahead of print)

    PubMed  Google Scholar 

  20. Kempfert J, Meyer A, Kim W-K et al (2016) Comparison of two valve systems for transapical aortic valve implantation: a propensity score-matched analysis. Eur J Cardio Thoracic Surg 49:486–492

    Article  Google Scholar 

  21. Kim W-K, Rolf A, Liebetrau C et al (2014) Detection of myocardial injury by CMR after transcatheter aortic valve replacement. J Am Coll Cardiol 64:349–357

    Article  PubMed  Google Scholar 

  22. Möllmann H, Kim W-K, Kempfert J et al (2014) Transfemoral aortic valve implantation of edwards SAPIEN XT without predilatation is feasible. Clin Cardiol 37:667–671

    Article  PubMed  Google Scholar 

  23. Walther T, Möllmann H, van Linden A, Kempfert J (2011) Transcatheter aortic valve implantation transapical: step by step. Semin Thorac Cardiovasc Surg 23:55–61

    Article  PubMed  Google Scholar 

  24. Möllmann H, Kempfert J, Hamm CW, Walther T (2010) Transcatheter aortic valve implantation. Herz 35:62–68

    Article  PubMed  Google Scholar 

  25. Abdel-Wahab M, Mehilli J, Frerker C et al (2014) Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement. JAMA 311:1503–1514

    Article  PubMed  Google Scholar 

  26. Ramazzina C, Knecht S, Jeger R et al (2014) Pacemaker implantation and need for ventricular pacing during follow-up after transcatheter aortic valve implantation. Pacing Clin Electrophysiol 37:1592–1601

    Article  PubMed  Google Scholar 

  27. Boerlage -VAN, Dijk K, Kooiman KM, Yong ZY et al (2014) Predictors and permanency of cardiac conduction disorders and necessity of pacing after transcatheter aortic valve implantation. Pacing Clin Electrophysiol 37:1520–1529

    Article  Google Scholar 

  28. Jilaihawi H, Chin D, Vasa-Nicotera M et al (2009) Predictors for permanent pacemaker requirement after transcatheter aortic valve implantation with the CoreValve bioprosthesis. Am Heart J 157:860–866

    Article  PubMed  Google Scholar 

  29. van der Boon RMA, Van Mieghem NM, Theuns DA et al (2013) Pacemaker dependency after transcatheter aortic valve implantation with the self-expanding Medtronic CoreValve System. Int J Cardiol 168:1269–1273

    Article  PubMed  Google Scholar 

  30. Urena M, Webb JG, Tamburino C et al (2014) Permanent pacemaker implantation after transcatheter aortic valve implantation: impact on late clinical outcomes and left ventricular function. Circulation 129:1233–1243

    Article  PubMed  Google Scholar 

  31. Urena M, Rodés-cabau J, Hospital BB, Heart Q (2015) EuroIntervention Managing heart block after transcatheter aortic valve implantation: from monitoring to device selection and pacemaker indications. EuroIntervention 11:W101–W105

    Article  PubMed  Google Scholar 

  32. Brignole M, Auricchio A, Baron-Esquivias G et al (2013) 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association. Eur Heart J 34:2281–2329

    Article  PubMed  Google Scholar 

  33. van der Boon RM, Nuis R-J, Van Mieghem NM et al (2012) New conduction abnormalities after TAVI-frequency and causes. Nat Rev Cardiol 9:454–463

    Article  PubMed  Google Scholar 

  34. Kindermann M, Hennen B, Jung J et al (2006) Biventricular versus conventional right ventricular stimulation for patients with standard pacing indication and left ventricular dysfunction. J Am Coll Cardiol 47:1927–1937

    Article  PubMed  Google Scholar 

  35. Chan JYS, Fang F, Zhang Q et al (2011) Biventricular pacing is superior to right ventricular pacing in bradycardia patients with preserved systolic function: 2-year results of the PACE trial. Eur Heart J 32:2533–2540

    Article  PubMed  Google Scholar 

  36. Stockburger M, Gomez-Doblas JJ, Lamas G et al (2011) Preventing ventricular dysfunction in pacemaker patients without advanced heart failure: results from a multicentre international randomized trial (PREVENT-HF). Eur J Heart Fail 13:633–641. doi:10.1093/eurjhf/hfr041

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Elizabeth Martinson, Ph.D., of the KHFI Editorial Office for her editorial assistance.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Helge Möllmann.

Ethics declarations

The ethics board of the state of Hessen, Germany, approved the study (FF 87/2010), which complies with the Declaration of Helsinki.

Conflict of interest

Helge Möllmann received speaker honoraria and/or travel grants from Edwards Lifesciences, St. Jude Medical, Boston Scientific (former Symetis SA). Luise Gaede and Johannes Blumenstein received travel grants from Edwards Lifesciences, St. Jude Medical, Boston Scientific (former Symetis SA). Won Keun Kim is a proctor for St. Jude Medical and Boston Scientific (former Symetis SA). Christian Hamm is part of the Medtronic Advisory Board. Johannes Sperzel received lecture honoria from Abbott and Zoll. All other authors have no conflict of interest regarding the submitted work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gaede, L., Kim, WK., Liebetrau, C. et al. Pacemaker implantation after TAVI: predictors of AV block persistence. Clin Res Cardiol 107, 60–69 (2018). https://doi.org/10.1007/s00392-017-1158-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-017-1158-2

Keywords

Navigation